ABN.AS: $40.75 ▲ 0.30 (0.74%)DSFIR.AS: $99.66 ▼ -0.99 (-0.98%)GMAB.CO: $2,487.00 ▲ 42.00 (1.72%)REP.MC: $29.21 ▼ -0.31 (-1.05%)SOON.SW: $267.80 ▲ 3.20 (1.21%)CRWD: $263.07 ▼ -11.97 (-4.35%)HPE: $70.13 ▼ -3.33 (-4.53%)AMD: $590.04 ▼ -18.06 (-2.97%)DELL: $574.99 ▼ -11.07 (-1.89%)PANW: $399.75 ▼ -19.03 (-4.54%)MRNA: $214.23 ▼ -10.77 (-4.79%)AAPL: $339.52 ▲ 2.88 (0.86%)AMZN: $259.82 ▼ -2.61 (-0.99%)MSFT: $539.81 ▲ 4.74 (0.89%)NVDA: $226.42 ▼ -2.86 (-1.25%)CIEN: $403.29 ▼ -46.48 (-10.34%)DDOG: $287.72 ▼ -5.54 (-1.89%)SNPS: $503.07 ▼ -6.92 (-1.36%)CAP.PA: $115.35 ▲ 0.30 (0.26%)TSCO.L: $511.00 ▲ 7.20 (1.43%)WKL.AS: $77.16 ▲ 2.16 (2.88%)

Company Details

Heart Test Laboratories, Inc.

HSCSW - NASDAQ

Identifiants & Marche

Ticker HSCSW
ISIN US42254E1120
CIK 0001468492
Bourse NASDAQ
Devise USD

Classification

Secteur Healthcare
Industrie Medical - Devices

Entreprise

Pays US
Siege N/A
Fondee N/A
Site Web Lien

Description

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.
Voir l'evolution du cours Retour